News

Crinetics Pharma's Paltusotine shows strong Phase 3 results for acromegaly. Click here to find out why CRNX stock is a Buy.
Growth hormone levels decreased from 13.5 ± 3.1 ... The authors concluded that long-term treatment with somatostatin analogs is effective and well tolerated.
Potential Strategy Against Blood Glucose Drops in Type 1 Diabetes Sep. 30, 2024 — Inhibiting the hormone somatostatin may be a new treatment strategy to prevent dangerous blood glucose drops in ...
such as drugs that regulate growth hormone, researchers noted. Consomatin also lasts far longer in the human body than somatostatin, because it contains an unusual amino acid that makes it harder ...
Crinetics (CRNX) announced that the European Medicines Agency has validated the marketing authorization application for paltusotine, the first ...
Growth hormone is involved with growth (proteins ... Salmon GH is controlled by a hypothalamic GH-releasing factor and a GH-inhibitory factor (somatostatin). Thyroid hormones appear to stimulate ...
Pasireotide, a new panreceptor analog, might control clinical symptoms and hormone release in patients resistant to standard somatostatin analog therapy. mTOR and tyrosine kinase inhibitors may ...